Trial · NCT01811147
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
NCT01811147, Phase 4, Completed, The Cleveland Clinic; results first posted 2019-12-02
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI. Trials, record NCT01811147. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01811147
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
- NCT number
- NCT01811147
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 192 participants, actual
- Lead sponsor
- The Cleveland Clinic
- Conditions
- Bipolar Disorder, Major Depression
- Interventions
- Selective Serotonin Reuptake Inhibitor (SSRI)
- First posted
- 2013-03-14
- Last updated
- 2019-12-02
- Results first posted
- 2019-12-02
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | HAM-D 17 Item: Hamilton Depression Rating Scale | 24 months | Hamilton depression rating scale (17-item HAM-D): Scores can range from 0 to 52: No depression (0-7); Mild depression (8-16); Moderate depression (17-23); and Severe depression (≥24). |
| Secondary | YMRS: Young Mania Rating Scale | 24 months | Young Mania Rating Scale: Scores can range from 0 to 60: In Remission/No Mania (0-8); Mild (9-12); Moderate (13-18); Severe (19-25); Very Severe (\>25) |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | HAM-D 17 Item: Hamilton Depression Rating Scale | 24 months | score on a scale | MEAN | |
| SECONDARY | YMRS: Young Mania Rating Scale | 24 months | score on a scale | MEAN |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| HAM-D 17 Item: Hamilton Depression Rating Scale | High Risk Depression | 6.6 | Standard Deviation 6.62 | score on a scale | |
| HAM-D 17 Item: Hamilton Depression Rating Scale | Low Risk Depression | 4.91 | Standard Deviation 4.11 | score on a scale | |
| HAM-D 17 Item: Hamilton Depression Rating Scale | Healthy Control | 2.333 | Standard Deviation 2.732 | score on a scale | |
| HAM-D 17 Item: Hamilton Depression Rating Scale | Bipolar | 3.75 | Standard Deviation 4.992 | score on a scale | |
| YMRS: Young Mania Rating Scale | High Risk Depression | 0.2 | Standard Deviation 0.561 | score on a scale | |
| YMRS: Young Mania Rating Scale | Low Risk Depression | 0 | Standard Deviation 0 | score on a scale | |
| YMRS: Young Mania Rating Scale | Healthy Control | 0 | Standard Deviation 0 | score on a scale | |
| YMRS: Young Mania Rating Scale | Bipolar | 1.75 | Standard Deviation 3.5 | score on a scale |
Source ClinicalTrials.gov
Participant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | High Risk Depression | 51 | |
| Overall Study | STARTED | Low Risk Depression | 56 | |
| Overall Study | STARTED | Healthy Control | 49 | |
| Overall Study | STARTED | Bipolar | 33 | |
| Overall Study | COMPLETED | High Risk Depression | 15 | |
| Overall Study | COMPLETED | Low Risk Depression | 11 | |
| Overall Study | COMPLETED | Healthy Control | 6 | |
| Overall Study | COMPLETED | Bipolar | 4 | |
| Overall Study | NOT COMPLETED | High Risk Depression | 36 | |
| Overall Study | NOT COMPLETED | Low Risk Depression | 45 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pregnancy | Pregnancy, puerperium and perinatal conditions | High Risk Depression | 2 | 51 | |
| other | Pregnancy | Pregnancy, puerperium and perinatal conditions | Low Risk Depression | 1 | 56 | |
| other | Pregnancy | Pregnancy, puerperium and perinatal conditions | Healthy Control | 0 | 49 | |
| other | Pregnancy | Pregnancy, puerperium and perinatal conditions | Bipolar | 0 | 33 | |
| other | Visit to Emergency Room | Social circumstances | High Risk Depression | 1 | 51 | |
| other | Visit to Emergency Room | Social circumstances | Low Risk Depression | 1 | 56 | |
| other | Visit to Emergency Room | Social circumstances | Healthy Control | 0 | 49 | |
| other | Visit to Emergency Room | Social circumstances | Bipolar | 0 | 33 | |
| other | Substance Abuse Treatment | Psychiatric disorders | High Risk Depression | 0 | 51 | |
| other | Substance Abuse Treatment | Psychiatric disorders | Low Risk Depression | 2 | 56 |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 adverse eventsAdverse event totals12
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | High Risk Depression | 0 | 51 |
| Total, all-cause mortality | Low Risk Depression | 0 | 56 |
| Total, all-cause mortality | Healthy Control | 0 | 49 |
| Total, all-cause mortality | Bipolar | 0 | 33 |
| Total, other adverse events | High Risk Depression | 3 | 51 |
| Total, other adverse events | Low Risk Depression | 4 | 56 |
| Total, other adverse events | Healthy Control | 0 | 49 |
| Total, other adverse events | Bipolar | 0 | 33 |
| Total, serious adverse events | High Risk Depression | 5 | 51 |
| Total, serious adverse events | Low Risk Depression | 3 | 56 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 adverse event totalsPapers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 30579045 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01811147
GET https://conductscience.org/api/trials/v1/NCT01811147/events?page=2